Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Vaccine|May 12, 2018
Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL groupTobias Svensson, Magdalena Kättström, Ylva Hammarlund, et al.
Blood|July 13, 2018
High-risk chronic lymphocytic leukemia in the era of pathway inhibitors: integrating molecular and cellular therapiesPeter Dreger, Paolo Ghia, Johannes Schetelig, et al.
Leukemia & Lymphoma|January 19, 2008
Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma GroupEva Kimby, Jesper Jurlander, Christian Geisler, et al.
Epigenetics|April 2, 2014
microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemiaStefan Deneberg, Meena Kanduri, Dina Ali, et al.
Plos One|December 3, 2010
Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphomaXiao Wang, Stefan Björklund, Agata M Wasik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophagesBjörn Engelbrekt Wahlin, Mohit Aggarwal, Santiago Montes-Moreno, et al.
Leukemia & Lymphoma|November 24, 2015
Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an updateBruce D Cheson, Wolfram Brugger, Gandhi Damaj, et al.
Blood|October 11, 2014
Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?Peter Dreger, Johannes Schetelig, Niels Andersen, et al.
Ejhaem|June 19, 2024
Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based studyTove Wästerlid, Caroline E Dietrich, Anna Oksanen, et al.
Leukemia & Lymphoma|February 17, 2012
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?Maciej Machaczka, Jan-Erik Johansson, Mats Remberger, et al.
Pageof 12